IGM Biosciences, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
IGM Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • IGM Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.96M, a 41% decline year-over-year.
  • IGM Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $15.1M, a 9.72% decline year-over-year.
  • IGM Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $17.7M, a 159% increase from 2022.
  • IGM Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $6.85M, a 4211% increase from 2021.
  • IGM Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $159K, a 91.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.7M +$10.9M +159% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $6.85M +$6.7M +4211% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $159K -$1.77M -91.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 $1.93M +$560K +41% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 $1.37M +$1.29M +1606% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 $80K -$13K -14% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 $93K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.